Super Crop Safe (530883)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 36.23% indicates strong demand and business expansion.
• P/B of 1.72 with book value at ₹7.91 provides a modest asset cushion.
• Price has moved well off the 52-week low of ₹6.82, showing market interest.
• Latest quarterly sales of ₹17 Cr show scale that could provide operating leverage if margins recover.

Concerns

• Latest quarter net profit is ₹0 Cr and annual profit growth is -60.44%, making the 32.70 P/E unjustified.
• ROE of 3.58% and ROCE of 5.57% are far below acceptable levels, suggesting weak moat and poor capital allocation.
• Piotroski F-Score of 4/9 points to weak financial health.
• No dividend, plus missing promoter holding and debt/equity data, limits transparency and shareholder returns.

AI Analysis

At ₹13.60, Super Crop Safe wears the mask of a growth story, with sales up 36.23% and a PEG below one. But Graham taught me to look through appearances. The latest quarter tells a harder truth: sales of ₹17 Cr produced zero net profit. Annual profit has collapsed by 60.44%. A P/E of 32.70 on falling earnings is not value; it is hope priced as certainty. The business earns a paltry ROE of 3.58% and ROCE of 5.57%. With returns like that, there is no economic moat and very little margin of safety. Book value of ₹7.91 offers some support, and at 1.72 times book I am not paying an outrageous asset price, but a low P/B cannot rescue a low return business unless management proves it can deploy capital profitably. Piotroski score of 4/9 reinforces my caution: financial health is weak, not strong. There is no dividend to reward patient shareholders, and missing promoter holding and debt/equity data mean I cannot fully trust or assess the governance and leverage picture. Charlie and I look for predictable earnings and honest, capable management. This company has sales growth but no earnings power; it may be a turnaround candidate, but that requires evidence, not narrative. I would wait until margins recover and return on capital moves decisively above 10%, or the price offers a far larger discount to intrinsic value. The 52-week range of ₹6.82 to ₹14.50 shows this is a volatile small-cap, and Mr. Market has already marked it up. At 32 times earnings with zero current profit, I am not a buyer today.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer